Introduction {#s1}
============

Diabetes Mellitus (DM) almost triples the risk of developing tuberculosis (TB) [@pone.0046502-Jeon1]--[@pone.0046502-Patel1]. India, the nation with the highest number of TB cases in the world, is also undergoing epidemic growth in DM rates. The estimated prevalence of DM in India in 2010 was 51 million and this is projected to increase to 70 million by 2025 [@pone.0046502-International1], [@pone.0046502-Ramachandran1]. In India, 15% of pulmonary tuberculosis cases have been estimated to be attributable to DM [@pone.0046502-Stevenson2]. An analysis of nutrition and DM changes in India also suggests that increased DM prevalence between 1998 and 2008 contributed to an increase in the total number of TB cases in the country which exceeded the rate of population growth in the same time period [@pone.0046502-Dye1]. These findings highlight the impact of the DM epidemic on TB incidence rates in the country.

A recent systematic review of the effect of DM on TB treatment outcomes showed that DM may delay sputum culture conversion, may increase the case fatality rate during treatment, and may increase relapse rates of TB after successful completion of treatment [@pone.0046502-Baker1]. A study from Kerala shows that non-drug resistant TB patients with DM were more likely to fail first line TB treatment as compared to those without DM [@pone.0046502-Balakrishnan1]. Therefore, active screening for DM among TB patients may provide an opportunity to identify previously undiagnosed diabetes and improve TB treatment outcomes through optimum diabetic care. However, neither international guidelines nor India\'s Revised National TB Control Programme (RNTCP) currently recommend active screening of TB patients for detection of DM.

DM is common in the south Indian state of Kerala (population 34.6 million), with an estimated community prevalence of 16% to 20% [@pone.0046502-RamanKutty1], [@pone.0046502-Menon1]. We therefore conducted this study to determine the overall prevalence of DM among TB patients and to assess whether routine screening of TB patients for DM within a programme setting might yield previously undiagnosed DM cases, offering an opportunity for earlier detection and treatment of DM. The specific objectives of this study were to determine (i) the overall prevalence of DM (self-reported and newly diagnosed) among TB patients registered for treatment under RNTCP in Kerala state (ii) additional yield of previously unknown DM as measured by glycosylated haemoglobin (HbA1c) and the Number needed to screen (NNS) to find a new case of DM and (iii) the factors associated with DM among TB patients.

Methods {#s2}
=======

Study Design {#s2a}
------------

This was a cross-sectional study of a sample of TB patients diagnosed and registered in 2011 in which self-report and HbA1c was used to diagnose DM.

Study Setting {#s2b}
-------------

The study was conducted in Kerala, the southernmost state of India. In 2010, approximately 25,000 patients were diagnosed and treated through 73 TB reporting units statewide [@pone.0046502-Central1]. According to national guidelines [@pone.0046502-Central2], sputum smear microscopy is performed for all TB suspects. Patients are diagnosed with pulmonary TB (PTB) if at least one initial sputum sample contains acid fast bacilli. Smear negative PTB cases are diagnosed by chest radiograph subsequent to negative results for repeated sputum smear microscopy, after two weeks of the first results. Extra-pulmonary TB (EPTB) cases are diagnosed by a combination of histopathology, mycobacteriology and/or clinical features. All TB patients are treated with a rifampicin containing, fully intermittent (thrice weekly), standardized treatment regimen delivered under direct observation. Patients are registered for treatment in one of the designated TB units of the state and monitored for their treatment outcome. TB cases are further classified as per standard WHO definitions [@pone.0046502-World1]. Kerala state has been proactive and ahead of the national efforts in providing diagnostic and treatment services for DM at secondary care level within its general health system at subsidized rates for the patients [@pone.0046502-Directorate1].

The national programme dealing with all non-communicable diseases including diabetes (NPCDCS for National programme for prevention and control of Cancer, Diabetes, Cardiovascular diseases and Stroke) is still in its early stages in India and is being piloted in 30 districts across the country with plans to extend it to 100 districts by the end of 2012. However, the Government of India is committed to achieve nationwide expansion in the 12th five year plan period (2012--17) [@pone.0046502-Ministry1]. In these pilot districts, diagnostic and treatment services for DM have been decentralized to primary care level, free of cost to the patients.

Sample size and Sampling {#s2c}
------------------------

All patients aged \>15 years diagnosed and registered with any type of TB in Kerala\'s 73 TB Units between June and July 2011 were eligible for this study. The sample size for the study was calculated based on an estimated prevalence of DM in TB patients of 25% with a precision of 5% and a design effect of two. Cluster sampling method was chosen with each TB unit considered a cluster. Of the 73 TB Units, 30 were selected randomly to create a representative sample of the state. Of the TB units selected, 22 TB units were predominantly rural and 8 TB units were predominantly urban, in line with the expected rural-urban distribution of the population in the state of Kerala. The number of patients enrolled in each cluster was proportionate to number of TB cases notified from each selected TU. In each TB unit, consecutively registered TB patients were enrolled until the required sample was achieved. The names of the TB units, sample size planned from each cluster and sample size achieved are shown in the table. ([Table 1](#pone-0046502-t001){ref-type="table"}. Details of the 30 TB Units (clusters) selected by cluster sampling for the study, Kerala, India, June--July 2011). The location of TB units selected is shown in the map. ([Figure 1](#pone-0046502-g001){ref-type="fig"}: Sampled TB units in Kerala to estimate the prevalence of Diabetes Mellitus among TB patients)

![Sampled TB units in Kerala to estimate the prevalence of Diabetes Mellitus among TB patients.](pone.0046502.g001){#pone-0046502-g001}

10.1371/journal.pone.0046502.t001

###### Details of the 30 TB Units (clusters) selected by cluster sampling for the study, Kerala, India, June--July 2011.
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  Name of the TB unit    Type of TB Unit   Population   Adult TB Case Notification October to December 2009   Sample size proposed   Sample Size achieved
  --------------------- ----------------- ------------ ----------------------------------------------------- ---------------------- ----------------------
  Adoor                       Rural          525924                             100                                    32                     30
  Alathur                     Rural          431834                             75                                     21                     21
  Chavakkad                   Rural          561856                             69                                     19                     12
  Cherthala                   Rural          554693                             74                                     25                     25
  Chirayinkeezhu              Rural          536603                             71                                     18                     0
  Chittur                     Rural          448880                             107                                    30                     30
  Kochi                       Urban          498868                             84                                     25                     25
  Irinjalakkuda               Rural          548386                             65                                     22                     20
  Kasaragod                   Rural          502522                             62                                     19                     8
  Karunagappally              Rural          467111                             82                                     27                     27
  Kollam_DTC                  Urban          803899                             120                                    32                     25
  Kothamangalam               Rural          248208                             39                                     11                     11
  Kottayam                    Urban          681484                             124                                    33                     34
  Koyilandy                   Urban          520464                             70                                     22                     22
  Mavelikkara                 Rural          561102                             100                                    29                     29
  Mukkam                      Rural          447704                             47                                     16                     16
  Neyyattinkara               Rural          508572                             64                                     19                     0
  Ottapalam                   Rural          485813                             92                                     24                     24
  Painavu                     Rural          259416                             18                                     7                      7
  Pala                        Rural          424809                             51                                     17                     17
  Palakkad_DTC                Urban          545474                             100                                    36                     36
  Payyannur                   Rural          463532                             53                                     12                     12
  Peroorkada                  Urban          500110                             60                                     17                     0
  Perumbavoor                 Rural          420324                             70                                     21                     13
  Ponnani                     Rural          423191                             44                                     14                     15
  Punalur                     Rural          483612                             78                                     25                     25
  Thalassery                  Urban          504638                             64                                     20                     16
  Thiruvalla                  Urban          468174                             60                                     17                     17
  Wadakkanchery               Rural          521066                             81                                     24                     19
  Wayanad_DTC                 Rural          265509                             35                                     15                     16
  Total                                                                                                               650                    552

Data Collection and analysis {#s2d}
----------------------------

Data were collected using a structured questionnaire to elicit demographic and clinical variables including a history of diabetes. For patients consenting to DM screening, blood samples were collected within one month of diagnosis of TB and glycosylated hemoglobin (HbA1c) levels were measured from whole blood using High Pressure Liquid Chromatography on a Biorad D10 Machine according to standard procedures, an NGSP (National Glycohemoglobin Standardization Program) accepted method with low co-efficient of variation and less likely to be affected by interfering substances. An HbA1c value of 6.5% or above was considered diagnostic of DM, in line with recommendations of American Diabetes Association and WHO [@pone.0046502-World2]--[@pone.0046502-Kumar1]. For patients with self-reported DM, a glycosylated hemoglobin (HbA1c) level \>7% was taken to indicate poorly controlled disease [@pone.0046502-American1]. We chose to measure glycosylated hemoglobin level as a tool to diagnose DM as it has multiple advantages over traditional fasting plasma glucose measurement. First, it is a valid method and is now recommended by all the leading technical agencies around the globe. Second, it is very convenient for the patient as blood sample can be drawn at the time of initial visit and does not require patient preparation in terms of being in the fasting state for 8 hours, which often places unnecessary burden on very sick patients. Third, it is least influenced by temporary changes in the levels of blood glucose due to various factors including acute infection like Tuberculosis.

We used Epi Info 7 (Version 7.0.8.0) to analyze the data and performed a complex sample analysis to account for the cluster sampling methodology [@pone.0046502-CDC1]. The main outcomes for analysis were the number and proportion (with 95% confidence interval) of TB patients with a diagnosis of DM (previously known and newly diagnosed), stratified by age, sex, place of residence and type of TB. Odds ratios with 95% confidence intervals have been used to describe the differences between groups. Multivariate analysis using logistic regression was done to calculate adjusted odds ratios. Only variables that were statistically significant (p\<0.05) in bivariate analysis were considered for multivariate analysis.

Ethics approval {#s2e}
---------------

Written informed consent was taken from all the study participants and from the parents in case of minors, ie, for participants of age 15 to 18 years, before enrollment in the study and those TB patients who were diagnosed to be having DM were linked to standard care available in the government health system which included counseling, lifestyle modification, specialist\'s consultation, anti-diabetic medications including insulin provided free of cost and management of complications. The study was approved by the ethics committee of National Tuberculosis Institute (NTI), Bangalore, India and the Ethical Advisory Group of The International Union against Tuberculosis and Lung Diseases (The Union).

Results {#s3}
=======

The overall prevalence of DM among TB patients disaggregated by age, sex, residence and type of TB is shown in [Table 2](#pone-0046502-t002){ref-type="table"} ([Table 2](#pone-0046502-t002){ref-type="table"} Prevalence of Diabetes Mellitus among tuberculosis patients registered for treatment in the state of Kerala, India, June--July 2011). There were 552 patients \[mean (SD) age 46 (15) years\] enrolled in the study. Three quarters of the patients were male and the majority were from a rural setting. New TB patients constituted 86% of all patients, and of these 65% had smear-positive pulmonary TB ([Table 2](#pone-0046502-t002){ref-type="table"}).

10.1371/journal.pone.0046502.t002

###### Prevalence of Diabetes Mellitus among tuberculosis patients registered for treatment in the state of Kerala, India, June--July 2011.
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  Characteristic                     Number of TB patients whose DM status was ascertained   Number with DM   Prevalence of DM (95% CI)
  --------------------------------- ------------------------------------------------------- ---------------- ---------------------------
  **Total**                                                   552                                 243             44.0 (38.8--49.3)
  **Sex**                                                                                                    
  Male                                                        420                                 208             49.5 (43.6--55.4)
  Female                                                      132                                  35             26.5 (19.1--33.9)
  **Age (years)**                                                                                            
  15--24                                                      57                                   4               7.0 (0.6--13.4)
  25--34                                                      70                                   15             21.4 (10.6--32.2)
  35--44                                                      114                                  44             38.6 (29.1--48.1)
  45--54                                                      134                                  74             55.2 (46.5--63.9)
  55--64                                                      106                                  67             63.2 (51.7--74.7)
  ≥65                                                         71                                   39             54.9 (42.1--67.7)
  **Residence**                                                                                              
  Urban                                                       107                                  51             47.6 (35.8--59.5)
  Rural                                                       445                                 192             43.1 (37.9--48.4)
  **Type of TB**                                                                                             
  New Smear Positive Pulmonary TB                             307                                 157             51.1 (44.3--57.9)
  New Smear Negative Pulmonary TB                             37                                   11             29.7 (17.7--41.7)
  New Extra-pulmonary TB                                      128                                  36             28.1 (18.4--37.8)
  Relapse                                                     35                                   20             57.1 (40.8--73.5)
  Treatment after Failure                                     19                                   9              47.3 (24.5--70.2)
  Treatment after Default                                     26                                   10             38.4 (18.3--58.5)

TB-Tuberculosis; DM- Diabetes Mellitus; CI-Confidence Interval; Number with DM includes self-reported, previously known cases and those newly diagnosed with a glycosylated hemogolobin level of ≥6.5%.

Of 552 TB patients assessed, 243 (44%) were found to have DM ([Table 2](#pone-0046502-t002){ref-type="table"}). The prevalence of DM was higher among males, those aged 50 years and above and among smear positive TB cases, particularly among Relapse TB cases.

Of 243 diabetics, 128 (23%) TB patients self-reported a previous diagnosis of DM and 115 (21%) were newly diagnosed to have DM, an additional yield of about 47%. ([Table 3](#pone-0046502-t003){ref-type="table"} Additional Yield of new cases of Diabetes Mellitus and Number Needed to Screen to diagnose a new case of DM among tuberculosis patients in the state of Kerala, India, June--July 2011). After excluding previously known DM, the number of TB patients that needed to be screened (NNS) to find one new case of DM was approximately 4 ([Table 3](#pone-0046502-t003){ref-type="table"}). The NNS ranged between 2--6 across all categories except for those aged 15--24 years in whom it was 53.

10.1371/journal.pone.0046502.t003

###### Additional Yield of new cases of Diabetes Mellitus and Number Needed to Screen to diagnose a new case of DM among tuberculosis patients in the state of Kerala, India, June--July 2011.
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  Characteristic                     Number of TB patients whose DM status was ascertained \[a\]   Number with previously known DM \[b\]   Number of DM newly diagnosed \[c\]   Additional Yield \[c/(b+c)\*100\]   Number needed to screen (NNS) \[(a−b)/c\]
  --------------------------------- ------------------------------------------------------------- --------------------------------------- ------------------------------------ ----------------------------------- -------------------------------------------
  **Total**                                                      552                                                128                                   115                                  47%                                     3.7
  **Sex**                                                                                                                                                                                                          
  Male                                                           420                                                108                                   100                                  48%                                     3.1
  Female                                                         132                                                20                                     15                                  43%                                     7.5
  **Age (years)**                                                                                                                                                                                                  
  15--24                                                         57                                                  3                                     1                                   25%                                    52.6
  25--34                                                         70                                                  4                                     11                                  73%                                     6.0
  35--44                                                         114                                                19                                     25                                  57%                                     3.8
  45--54                                                         134                                                44                                     30                                  41%                                     3.0
  55--64                                                         106                                                38                                     29                                  43%                                     2.3
  ≥65                                                            71                                                 20                                     19                                  49%                                     2.6
  **Residence**                                                                                                                                                                                                    
  Urban                                                          107                                                37                                     14                                  27%                                     5.0
  Rural                                                          445                                                91                                    101                                  53%                                     3.5
  **Type of TB**                                                                                                                                                                                                   
  New Smear Positive Pulmonary TB                                307                                                87                                     70                                  45%                                     3.1
  New Smear Negative Pulmonary TB                                37                                                  4                                     7                                   64%                                     4.7
  New Extra-pulmonary TB                                         128                                                15                                     21                                  58%                                     5.3
  Relapse                                                        35                                                 12                                     8                                   40%                                     3.3
  Treatment after Failure                                        19                                                  7                                     2                                   22%                                     6.0
  Treatment after Default                                        26                                                  3                                     7                                   70%                                     3.3

TB-Tuberculosis; DM- Diabetes Mellitus; NNS-Number needed to screen is defined as the reciprocal of the prevalence of newly diagnosed DM after excluding self-reported previously known cases of DM.

Results of the bivariate and multivariate analysis are presented in [Table 4](#pone-0046502-t004){ref-type="table"}. ([Table 4](#pone-0046502-t004){ref-type="table"} Factors associated with Diabetes Mellitus among tuberculosis patients registered for treatment in the state of Kerala, India, June--July 2011). Male sex and age above 50 years were significantly associated with a diagnosis of DM and remained independently associated even after adjusting for other variables in a logistic regression model ([Table 4](#pone-0046502-t004){ref-type="table"}).

10.1371/journal.pone.0046502.t004

###### Factors associated with Diabetes Mellitus among tuberculosis patients registered for treatment in the state of Kerala, India, June--July 2011.
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  Characteristic                   Unadjusted Odds Ratio (95% CI)              Adjusted Odds Ratio (95% CI) [\#](#nt105){ref-type="table-fn"}
  -------------------- ------------------------------------------------------ ----------------------------------------------------------------
  **Sex**                                                                     
  Male                  **2.7 (1.8--4.0)** [\*](#nt104){ref-type="table-fn"}        **2.3 (1.5--3.6)** [\*](#nt104){ref-type="table-fn"}
  Female                                        Ref                                                         Ref
  **Age (years)**                                                             
  ≥50                   **3.0 (2.2--4.3)** [\*](#nt104){ref-type="table-fn"}        **2.8 (2.0--4.0)** [\*](#nt104){ref-type="table-fn"}
  \<50                                          Ref                                                         Ref
  **Residence**                                                               
  Urban                                    1.2 (0.7--1.9)                                                    NA
  Rural                                         Ref                           
  **Type of TB**                                                              
  New                                           Ref                                                          NA
  Previously treated                       1.2 (0.8--2.0)                     

TB-Tuberculosis; DM- Diabetes Mellitus; NA-Not applicable.

*P* value less than 0.05;

\- adjusted for age and sex using Logistic regression.

Of 128 patients with a self-reported history of DM, 107 (84%) (95% CI 76.0--89.5) had a glycosylated haemoglobin level equal to or more than 7%, indicating poorly controlled DM.

Discussion {#s4}
==========

We found a high prevalence of DM amongst TB patients registered under RNTCP in the state of Kerala, India and this was significantly associated with male sex and age above 50 years. About one quarter of the patients gave a self-reported history of DM, and this was more common in those living in an urban environment and aged 50 years and above. This association with urban residence may indicate lifestyle practices that predispose to DM or better access to diagnosis of DM in urban settings. Of concern was the finding that the majority of these self-reported patients had poorly controlled DM, defined as glycosylated haemoglobin levels greater than or equal to 7%. This is as per the recommended glycemic goals for nonpregnant adults by American Diabetes Association which is HbA1c level of \<7% corresponding to a preprandial capillary plasma glucose 70--130 mg/dl (3.9--7.2 mmols/l) to define the control status of diabetes [@pone.0046502-American1]. In those with no self-reported history of DM, over one quarter had glycosylated haemoglobin levels greater than or equal to 6.5%, which is recognised by WHO as diagnostic of DM. In total, nearly half (44%, 95% CI 38.8--49.3) of the TB patients in Kerala were found to have DM, the highest reported prevalence of DM among TB patients to date. Furthermore 115 (21%) TB patients were found to have previously-undiagnosed DM. These findings are an alarming signal that DM should be considered and investigated in all TB patients in Kerala. This is highly justified given the high returns in terms of additional yield of newly diagnosed DM cases found in our study. The number needed to screen (NNS) to find one new case of DM was just four overall and ranged mainly from two to six, with the exception of the age group 15--24 years in whom it was about 50. This indicates that the strategy of routine screening of all TB patients for DM is likely to be cost-effective.

The high prevalence of DM amongst TB patient in the state follows a similar pattern of high prevalence of DM in the general population. Prevalence of DM as reported by the community serveys using blood sugar estimation among the general adult population in the state is high (16--20%) and is higher than that of the rest of the country [@pone.0046502-Menon1]. On the other hand, prevalence of tuberculosis transmission, is less in Kerala compared to the rest of the country [@pone.0046502-Kumar2]. TB patients of Kerala are older than those in the rest of India and DM could be one of the important factors influencing tuberculosis incidence in Kerala.

The strengths of this study are that large numbers of TB patients were consecutively enrolled in 30 reporting units across Kerala state, India, and therefore this cohort is probably representative of the state. However, this may not be representative of the situation in India because the prevalence of DM in Kerala is higher than that reported nationally and from other states in the country [@pone.0046502-Ramachandran2]. Another strength is that glycosylated haemoglobin levels were measured on all patients. This measurement provides an index of blood glucose levels over a period 2--3 months and is not subject to the rapid swings that can occur with random and fasting blood glucose measurements. Blood glucose levels at a specific moment in time can reflect recent diet and may also be affected by physiologic stress such as active tuberculosis as well as anti-TB treatment. Possible limitations of the study include the lack of information on factors such as alcohol intake or use of other drugs which might affect glycosylated haemoglobin levels. As an infectious disease, TB may temporarily elevate blood glucose levels resulting in false-positive diagnoses of diabetes if investigations are done too early. Several observational studies have shown that prevalence of hyperglycemia decreases with TB treatment and hence more research with multiple measurements during the course of treatment is required to define the optimal timing of screening for DM [@pone.0046502-World3].

We know of no other prospective study that has measured glycosylated haemoglobin levels in patients with TB in India. There have been studies conducted in India assessing the prevalence of DM in TB patients by meausrement of random and fasting blood glucose levels, and these have found prevalence levels that vary from 2% to 20% [@pone.0046502-Goyal1]--[@pone.0046502-Tripathy1]. Routine screening of TB patients for DM using random and fasting blood glucose level measurements by TB service providers in Kerala had reported a prevalence of 26% among TB patients of age 15 years or more [@pone.0046502-Sreenivas1]. Routine screening of multi drug resistant TB patients treated under RNTCP in Kerala with fasting and post meal blood glucose levels showed a prevalence of DM of 40%. A study similar to our study measuring glycosylated haemoglobin by Blanca et. al in Texas where community prevalence of DM was 19% reported a 39% prevalence of DM among TB patients [@pone.0046502-Restrepo1].

Policy implications {#s4a}
-------------------

This study has important policy implications. First, it is advisable to perform similar studies in different states in India using the same methodology in order to get a good measure of DM prevalence in TB patients across the country. Second, as is the case with HIV in sub-Saharan Africa, it will be essential to ask TB patients routinely about whether or not they have DM. If patients do give a self-reported history of DM, then they must be referred to appropriate DM care as most of the patients in this study had poorly controlled diabetes disease. TB patients with DM have an increased risk of death and this may be reduced through better DM control and treatment. Third, the study suggests it is important to routinely and actively screen all TB patients for DM, including those who do not self-report the disease. The major question is how to do this most effectively and efficiently [@pone.0046502-Jeon2]. Although glycosylated haemoglobin would appear to be the best way to screen as it is relatively unaffected by active TB and anti-TB drugs, it is a costly laboratory investigation which might be difficult to scale up and to use in peripheral health facilities. This requires a cost-effectiveness analysis. Fourth, there is limited information on various aspects of interaction between TB and DM including optimal tools and strategies for collaboration. This urgently calls for research - both clinical and operational research - to understand these interactions better and optimize the intervention strategies [@pone.0046502-World3]. Finally, it is important to have a well functioning non-communicable disease control programme linked with the TB control programme in settings where the prevalence of DM among TB patients is high. The recently published WHO-Union collaborative framework for care and control of DM-associated tuberculosis is a good template for action and should be considered for implementation by the national programmes [@pone.0046502-World3].

Conclusions {#s5}
===========

In conclusion, this study has shown a high prevalence of DM in patients with active TB, both for self-reported DM and for patients in whom the disease was not suspected, and supports routine screening of TB patients for DM. However, the best way of doing this needs to be established by futher operational research studies.
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